Eaton Vance Management Bausch Health Companies Inc. Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Eaton Vance Management holds 43,260 shares of BHC stock, worth $352,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,260

Previous 43,260 -0.0%

Holding current value

$352,569

Previous $362,000 17.68%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $5,993 - $20,061	-849 Reduced 1.92%	43,260 $362,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1,425 - $1,834	66 Added 0.15%	44,109 $1.01 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $10,902 - $13,750	-474 Reduced 1.06%	44,043 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $70,187 - $84,258	-2,803 Reduced 5.92%	44,517 $1.21 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $187,374 - $223,373	6,831 Added 16.87%	47,320 $1.39 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $43,658 - $70,238	-2,043 Reduced 4.8%	40,489 $1.29 Million
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $1.68 Million - $2.32 Million	-110,000 Reduced 72.12%	42,532 $885,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $838 - $1,292	63 Added 0.04%	152,532 $2.79 Million
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $368,355 - $621,855	19,500 Added 14.67%	152,469 $4.56 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $2.74 Million - $3.41 Million	132,969 New	132,969 $3.41 Million

Others Institutions Holding BHC

# of Institutions

275

Shares Held

279M

Call Options Held

5.68M

Put Options Held

17.4M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.95B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Bausch Health Companies Inc. Transaction History